With a list price of $22,600 when administered every six weeks, Keytruda is now the top-selling drug ... Gardasil has become ...

If a company shows a lot of potential, investors are often willing to pay a premium and take on some risk in exchange for ...

The Zacks Research Daily presents the best research output ... later in the decade. However, Merck beat second-quarter estimates for earnings and sales. Products like Keytruda and Gardasil have ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The company has previously reached settlement agreements with more than 20 other generics ... a big victory for Merck, given that Januvia remains its third best-selling product after cancer ...

a significant contribution from new products like Welireg and Vaxneuvance vaccine and the Animal Health segment can keep driving top-line growth. Merck is pinning hopes on PAH drug Winrevair to ...

At the highest dose tested, Vaxcyte’s shot elicited a stronger immune response against 18 of the 20 strains compared with ...

Over more than 20 years in the pharma industry ... and to direct R&D efforts where they can best help patients. To achieve this objective, in 2017, Merck launched a first-of-its-kind initiative ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where Merck & Co ... fast with over 2,000 products being in the pipeline.

We recently compiled a list of the 10 Best Defensive Stocks According to Reddit. In this article, we will look at where Merck & Co., Inc. (NYSE ... We compiled an initial list of 20 stocks and then ...